Skip to main content

Advertisement

Log in

Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Malignant phyllodes tumor of the breast is a rare neoplasm for which clinical findings remain insufficient for determination of optimal management. We examined the clinical behavior of these lesions in an attempt to determine appropriate management. We evaluated long-term outcome and clinical characteristics of malignant phyllodes tumors arising from fibroadenomas of the breast.

Methods

A total of 173 patients were given a diagnosis of phyllodes tumor and underwent surgery at the Cancer Institute Hospital in Japan between January 1980 and December 1999. Of these patients, 39 (22.5%) were given a diagnosis of malignant phyllodes tumor; in three of these cases, detailed medical records were lost. Malignant phyllodes tumors were classified into two groups based on history of malignant transformation. Of the 36 malignant cases, 11 (30.6%) were primary and were given a diagnosis of fibroadenoma, experienced recurrence during the follow-up period, and were diagnosed with malignant phyllodes tumor (cases with a history of fibroadenoma). The other group was defined as cases without history of fibroadenoma and in whom lesions initially occurred as malignant phyllodes tumors. Based on differences between the two groups, overall survival curves were plotted using the Kaplan–Meier method, and statistical comparisons were performed using the log-rank test and Peto and Peto’s test.

Results

The outcome of cases with history of fibroadenoma was significantly better than that of cases without history of fibroadenoma.

Conclusions

Patients with malignant phyllodes tumors but without prior history of malignant transformation who exhibit rapid growth within 6 months require aggressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Anderson BO, Lawton TJ, Lehman CD, Moe RE. Phyllodes tumors. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Disease of the breast. 3rd ed. Philadelphia: Lippincott Williams & Wilkins publishers; 2004. p. 991–1006.

    Google Scholar 

  2. McDivitt RW, Urban JA, Farrow JH. Cystosarcoma phyllodes. Johns Hopkins Med J. 1967;120:33–45.

    PubMed  CAS  Google Scholar 

  3. Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer. 1995;10:1779–85.

    Article  Google Scholar 

  4. Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, et al. Analysis of the progression of fibroepithelial tumors of the breast by PCR-based clonality assay. J Pathol. 2002;197:575–81.

    Article  PubMed  Google Scholar 

  5. Valdes EK, Boolbol SK, Cohen J-M, Feldman SM. Malignant transformation of a breast fibroadenoma to cystsarcoma phyllodes: case report and review of the literature. Am Surg. 2005;71:348–53.

    PubMed  Google Scholar 

  6. Pietruszka M, Barnes L. Cystsarcoma phyllodes: clinicopathologic analysis of 42 cases. Cancer. 1978;41:1974–83.

    Article  PubMed  CAS  Google Scholar 

  7. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc Ser A Stat Soc. 1972;135:185–206.

    Google Scholar 

  8. Chaney AW, Pollack A, Mcneese MD, Zagars GK, Pister PWT, Pollock RE, et al. Primary treatment of cystsarcoma phyllodes of the breast. Cancer. 2000;89:1502–11.

    Article  PubMed  CAS  Google Scholar 

  9. Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumors of the female breast. Association of primary therapy with cause-specific survival from the surveillance, epidemiology, and end results (SEER) program. Cancer. 2006;107:2127–33.

    Article  PubMed  Google Scholar 

  10. Asoglu O, Ugurlu MM, Blanchard K, Grant CS, Reynolds C, Cha SS, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11:1011–7.

    Article  PubMed  Google Scholar 

  11. Fou A, Schnabel FR, Hamele-Bena D, Wei XJ, Cheng B, Tamer ME, et al. Long-term outcomes of malignant phyllodes tumors patients: an institutional experience. Am J Surg. 2006;192:492–5.

    Article  PubMed  Google Scholar 

  12. Chen W-H, Cheng S-P, Tzen C-Y, Yang T-L, Jeng K-S, Liu C-L, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91:185–94.

    Article  PubMed  Google Scholar 

  13. Tan EY, Hoon TP, Yong WS, Wong HB, Hui HG, Yeo AWY, et al. Recurrent phyllodes tumors of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76:476–80.

    Article  PubMed  Google Scholar 

  14. Foxcroft LM, Evans EB, Porter AJ. Difficulties in the pre-operative diagnosis of phyllodes tumors of the breast: a study of 84 cases. Breast. 2006;27:27–37.

    Google Scholar 

Download references

Acknowledgments

We are grateful for the secretarial assistance provided by Ms. Rie Gokan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makoto Abe.

About this article

Cite this article

Abe, M., Miyata, S., Nishimura, S. et al. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer 18, 268–272 (2011). https://doi.org/10.1007/s12282-009-0185-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-009-0185-x

Keywords

Navigation